Papers
3
Total Citations
43
H-Index
2
About
Wei-Che Wu is a urological surgeon and clinical researcher whose work centers on the surgical management of upper tract urothelial carcinoma (UTUC), a malignancy of the renal pelvis and ureter that carries particular significance in Taiwan, where incidence rates notably exceed those seen in Western populations. Wu has made meaningful contributions to the comparative evaluation of minimally invasive surgical approaches for nephroureterectomy, the definitive treatment for UTUC, examining hand-assisted, laparoscopic, and robotic techniques with respect to both oncological outcomes and surgical safety. His most-cited work (24 citations), drawn from the large-scale Taiwan UTUC Collaboration Group dataset, provides one of the field's more rigorous head-to-head comparisons of these operative strategies. Earlier research conducted through the Taiwan Robot Urological Surgery Team (TRUST) — accumulating 17 citations — helped establish the feasibility and early outcomes of robot-assisted nephroureterectomy across multiple Taiwanese institutions. Together, Wu's publications reflect a sustained commitment to advancing minimally invasive urologic oncology, refining surgical technique, and generating region-specific evidence that addresses the disproportionate burden of UTUC in East Asian patients, particularly women and those with renal insufficiency.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3